Solid Biosciences Inc reports results for the quarter ended in March - Earnings Summary

Solid Biosciences

11/05/2023 14:22

* Solid Biosciences Inc  SLDB.OQ  reported a quarterly
adjusted
loss of $1.50​​ per share for the quarter ended in March. The
mean expectation of four analysts for the quarter was for a loss
of $2.05 per share.
    * Reported revenue was zero​; analysts expected $1.47
million. 
    * Solid Biosciences Inc's reported EPS for the quarter was a
loss
of $1.50​.
    * The mean earnings estimate of analysts had fallen by
about 117.6% in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Solid Biosciences Inc shares had risen by 30.8% this
quarter and
gained 15.2% so far this year.
    * The company reported a quarterly loss of $30.07 million.
    * Wall Street's median 12-month price target for Solid
Biosciences
Inc is $8.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 01:22 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -2.05          -1.50          Beat
 Dec. 31 2022      -1.65          -2.82          Missed
 Sep. 30 2022      -2.67          -2.71          Missed
 Jun. 30 2022      -3.15          -3.30          Missed